...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Multiple Alterations of Canalicular Membrane Transport Activities in Rats with CCl(4)-induced Hepatic Injury.
【24h】

Multiple Alterations of Canalicular Membrane Transport Activities in Rats with CCl(4)-induced Hepatic Injury.

机译:CCl(4)诱导的肝损伤大鼠的膜细胞转运活性的多种变化。

获取原文
获取原文并翻译 | 示例
           

摘要

The influence of CCl(4)-induced experimental hepatic injury (CCl(4)-EHI) on the expression and transport activities of primary active transporters on the canalicular membrane, including P-glycoprotein (P-gp), a bile salt export pump (Bsep) and a multidrug resistance associated protein2 (Mrp2), was assessed. CCl(4)-EHI was induced by an intraperitoneal injection of CCl(4) to rats at a dose of 1 ml/kg 24 h prior to the preparation of canalicular liver plasma membrane (cLPM) vesicles and pharmacokinetic studies. The expression of each transporter was measured for the vesicles via Western blot analysis at 6, 12, 24, 36, and 48 h after the injection of CCl(4). The in vivo canalicular excretion clearance (CL(exc)) of [(3)H]daunomycin, [(3)H]taurocholate and [(3)H]17beta-estradiol-17beta-D-glucuronide (E(2)17betaG), representative substrates of P-gp, Bsep, and Mrp2, respectively, was determined following an i.v. infusion to rats. The uptake of each substrate into cLPM vesicles in the presence of ATP was also measured by a rapid filtration technique. As the result of the CCl(4)-EHI, the protein level of transporters was altered as a function of time in multiple manners; it was increased by 3.6-fold for P-gp, unchanged for Bsep, and decreased by 73% for Mrp2 at 24 h. The in vivo CL(exc) and the intrinsic uptake clearance into cLPM vesicles (CL(int)) at 24 h after the CCl(4) injection (CCl(4)-EHI(24 h)) were also influenced by the EHI in a similar manner; they were increased by 1.8- and 1.9-fold for daunomycin, unchanged for taurocholate, and decreased by 41 and 39% for E(2)17betaG, respectively, consistent with multiple alterations in the expression of the relevant transporters.
机译:CCl(4)诱导的实验性肝损伤(CCl(4)-EHI)对主要活性转运蛋白在小管膜上的表达和转运活性的影响,包括P-糖蛋白(P-gp),胆盐输出泵(Bsep)和多药耐药相关蛋白2(Mrp2)进行了评估。 CCl(4)-EHI是在准备小管肝质膜(cLPM)囊泡和药代动力学研究之前24小时以1 ml / kg的剂量向大鼠腹腔注射CCl(4)诱导的。注射CCl(4)后6、12、24、36和48 h通过Western blot分析测量每个转运蛋白的表达。 [(3)H]道诺霉素,[[3] H]牛磺胆酸盐和[(3)H] 17beta-雌二醇-17beta-D-葡萄糖醛酸(E(2)17betaG)在体内的小管排泄清除率(CL(exc)) ),在静脉注射后分别测定P-gp,Bsep和Mrp2的代表性底物给大鼠输液。还通过快速过滤技术测量了在ATP存在下每种底物对cLPM囊泡的摄取。作为CCl(4)-EHI的结果,转运蛋白的蛋白质水平以多种方式随时间变化。在24小时内,P-gp增加了3.6倍,Bsep增加了3.6倍,Mrp2增加了73%。 CCL(4)注射(CCl(4)-EHI(24 h))后24小时体内的CL(exc)和内在吸收进入cLPM囊泡(CL(int))也受EHI影响类似的方式对于道诺霉素,它们分别增加了1.8倍和1.9倍,对于牛磺胆酸,它们不变,而对于E(2)17betaG,它们分别降低了41%和39%,这与相关转运蛋白的表达发生了多种变化一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号